Cadila’s U.S. facility in St. Louis cited by FDA for 11 observations: report

3rd June 2019 Uncategorised 0

Cadila Healthcare’s U.S. drug manufacturing facility in St. Louis was cited by the FDA for observations in the wake of the company’s Moraiya, India, plant getting tagged by the regulatory agency for a dozen observations last month.

More: Cadila’s U.S. facility in St. Louis cited by FDA for 11 observations: report
Source: fierce